Avalo insider plans sale of 5,037 AVTX shares

AVTX insider Mittie Doyle notified an intention to sell 5,037 shares of common stock on 08/17/2026, tied to an exercise of stock options, with a referenced value of $98,674.83.

Rhea-AI Filing Summary

AVTX insider Mittie Doyle notified an intention to sell 5,037 shares of common stock on 08/17/2026, tied to an exercise of stock options, with a referenced value of $98,674.83. The notice also lists recent Rule 10b5-1 sales of AVTX common stock over the prior three months with specified share counts and dollar amounts.

Key Figures

Shares to be sold: 5,037 shares Referenced value of covered securities: $98,674.83 10b5-1 sale 08/10/2026: 679 shares; $13,580.00 +4 more

7 metrics

Shares to be sold 5,037 shares Common shares covered for sale on 08/17/2026 tied to stock option exercise

Referenced value of covered securities $98,674.83 Value associated with 5,037 common shares listed for sale

10b5-1 sale 08/10/2026 679 shares; $13,580.00 Common stock sale labeled as 10b5-1 for Mittie Doyle

10b5-1 sale 07/27/2026 1,000 shares; $20,000.00 Common stock sale labeled as 10b5-1 for Mittie Doyle

10b5-1 sale 06/30/2026 4,654 shares; $93,080.00 Common stock sale labeled as 10b5-1 for Mittie Doyle

10b5-1 sale 06/23/2026 1,450 shares; $26,100.00 Common stock sale labeled as 10b5-1 for Mittie Doyle

10b5-1 sale 05/28/2026 679 shares; $10,864.00 Common stock sale labeled as 10b5-1 for Mittie Doyle

Key Terms

Form 144, 10b5-1 Sales, Exercise of Stock Options, Executive Financial Services

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Sales regulatory

"10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Common | 08/17/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AVTX’s Form 144 filed by Mittie Doyle disclose?

It discloses an intention to sell 5,037 AVTX common shares on 08/17/2026 related to an exercise of stock options, along with a history of recent Rule 10b5-1 sales in the past three months.

How many AVTX shares are planned to be sold in the upcoming transaction?

The notice covers a planned sale of 5,037 AVTX common shares. These shares are associated with an exercise of stock options dated 08/17/2026, with an indicated aggregate value of about $98,674.83 for the covered securities.

What prior AVTX stock sales are reported for Mittie Doyle?

The disclosure lists several 10b5-1 sales of AVTX common stock: 679 shares on 08/10/2026, 1,000 shares on 07/27/2026, 4,654 shares on 06/30/2026, 1,450 shares on 06/23/2026, and 679 shares on 05/28/2026.

What dollar amounts are associated with Mittie Doyle’s recent AVTX stock sales?

The recent 10b5-1 AVTX stock sales show aggregate amounts of $13,580.00, $20,000.00, $93,080.00, $26,100.00, and $10,864.00, corresponding respectively to the trades on 08/10/2026, 07/27/2026, 06/30/2026, 06/23/2026, and 05/28/2026.

How are the upcoming AVTX shares being obtained for sale?

The 5,037 AVTX common shares referenced for sale on 08/17/2026 are tied to an exercise of stock options by the issuer, with the exercise method identified as a cash transaction on that same date.

Are Mittie Doyle’s AVTX stock sales under a Rule 10b5-1 plan?

The recent AVTX stock sales are labeled as 10b5-1 Sales for Mittie Doyle. This wording indicates they are associated with Rule 10b5-1 trading arrangements, which are pre-established instructions for trading company stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:49 PM Accepted by SEC EDGAR 08/17/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001918845
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AVALO THERAPEUTICS, INC.
SEC File Number	001-37590
Address of Issuer	1500 Liberty Ridge Drive, Suite 321 Wayne PENNSYLVANIA 19087
Phone	4105228707
Name of Person for Whose Account the Securities are To Be Sold	MITTIE DOYLE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5037	98674.83	53629989	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Exercise of Stock Options	Issuer			5037	08/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	08/10/2026	679	13580.00
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	07/27/2026	1000	20000.00
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	06/30/2026	4654	93080.00
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	06/23/2026	1450	26100.00
10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087	Common	05/28/2026	679	10864.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mittie Doyle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)